2021 American Transplant Congress

Tuesday, June 8, 2021

6:00pm-6:05pm

Primary Outcome of OPTIMAL: A Prospective Multicenter Trial of Immunosuppression Withdrawal (ISW) in Stable Adult Liver Transplant (LT) Recipients

S. Chandran¹, K. Mason², L. F. Sun¹, N. Tanimine³, M. DesMarais¹, B. Burrell¹, J. F. Markmann³

Late Breaking: All Organs  •  Virtual

6:05pm-6:10pm

A Cost Benefit Analysis of Different Minimal Access Donor Nephrectomy Techniques Performed at a Busy Transplant Centre

H. Sharma¹, A. Odougoudar², A. Sharma², D. Ridgway², A. Hammad², S. Mehra²

A Penny for Your Thoughts: the Economics and Psychosocial Aspects of Transplant  •  Virtual

6:05pm-6:10pm

AT-1501, a Novel and Clinically Applicable CD40L Specific Monoclonal Antibody, Promotes Islet Allograft Survival in Nonhuman Primates

D. Berman¹, N. Kenyon¹, M. Willman¹, A. Gill², S. Perrin³, C. Ricordi¹

Xenotranplantation and Preclinical Studies  •  Virtual

6:05pm-6:10pm

Eosinophils Attenuate Hepatic Ischemia Reperfusion Injury in Mice Through St2-Dependent Il-13 Production

Y. Yang, Y. Wang, M. Wang, J. Jeong, L. Xu, Y. Wen, C. Emontzpohl, W. Dar, C. Ju

Ischemia Reperfusion & Organ Rehabilitation  •  Virtual

6:05pm-6:10pm

Outcomes of Short-Duration Anti-Viral Prophylaxis for Hepatitis C Positive Donor Kidney Transplants

G. Gupta, I. Yakubu, P. Kimball, L. Kang, K. Mitchell, M. Shinbashi, D. Kumar, I. Moinuddin, L. Kamal, A. King, C. Bhati, M. Levy, A. Cotterell, A. Sharma, R. Sterling

Hepatitis C  •  Virtual

6:05pm-6:10pm

Pilot Study for the Use of Shortened Preemptive Therapy with Glecaprevir/pibrentasvir (g/p) and Ezetimibe in Hepatitis C Seronegative Solid Organ Transplant Recipients (Kidney and Heart) of Hepatitis C Viremic Donors

B. Aqel¹, H. Khamash², A. Moss³, D. E. Steidley⁴, R. C. Dickson¹

Surgical Issues and Deceased Donor Management  •  Virtual

6:05pm-6:10pm

Pre- Kidney Donation Pregnancy Complications and Long-Term Outcomes

E. Helgeson¹, E. F. Palzer¹, D. Vock¹, A. Matas²

Live Kidney Donation  •  Virtual

6:05pm-6:10pm

Survival After Heart Transplant vs. Simultaneous Heart Kidney Transplant by Degrees of Renal Dysfunction at Engraftment in the United States: A Multivariable Analysis

S. M. Riad¹, M. Aljuhani¹, S. Jackson², T. Alexy¹, H. Wadie³, C. Martin¹, R. Kandaswamy⁴

Late Breaking: All Organs  •  Virtual

6:10pm-6:15pm

Cost-Effectiveness Analysis of Short-Duration Anti-Viral Prophylaxis for Hepatitis C Positive Donor Kidney Transplants

I. Yakubu, Y. Zhang, S. Ijioma, N. V. Carroll, J. Patterson, R. Sterling, G. Gupta

Hepatitis C  •  Virtual

6:10pm-6:15pm

Donor Service Area Characteristics Impacting Liver and Kidney Deceased Donor Population

C. O. Warren, A. Zarrinpar

Surgical Issues and Deceased Donor Management  •  Virtual